This week on BackTable: host Sabeen Dhand interviews vascular surgeon Dr. Sean Lyden about percutaneous transmural arterial bypass (PTAB), a new therapy for treating occlusive superficial femoral artery (SFA) disease.
Dr. Lyden serves as the Chairman of Vascular Surgery at Cleveland Clinic. He starts off the discussion by conveying the severity of SFA chronic total occlusion (CTO) and walks us through what PTAB therapy is. They then cover the steps and general principles of using the DETOUR technology.
Throughout the episode, Dr. Lyden and Sabeen discuss the structure and key takeaways of both the DETOUR 1 and DETOUR 2 trials, held in Europe and the United States respectively. They also cover major questions, such as DVT and PE risk, patency of femoral vein following DETOUR intervention, and overall device cost.
They conclude the episode with future directions of the now FDA-approved DETOUR device, and when and how vascular and interventional physicians can incorporate the new technology into their practice. Sean and Sabeen also contrast prior treatment options with the recent DETOUR trials to highlight how longer calcified / occluded SFA lesions now have a viable, effective, and safe endovascular treatment option. Listen below to learn more! #medEd #collaborativelearning #interventionalradiology #vascularsurgery #interventionalcardiology #endovascular #podcast
Thank you to our sponsor for this episode Endologix LLC!
Srini Tummala MD FSIR FSVM Nicholas Petruzzi Blake Parsons Jim Melton Krishna Mannava, MD, FACS, RPVI Neal Khurana, MD, RPVI Chad Laurich Aparna Baheti MD Kyle Cooper Donald Garbett, MD, RPVI Mary Costantino, MD Aneesa Majid, MD MBA FSIR CPE Ian Wilson, MD Raj Khalsa, MD Kumar Madassery Lorenzo Patrone Vascupedia Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM Bryan T Fisher Sr., MD Francis Caputo Lee Kirksey Raghu Kolluri, MD, MS, RVT Dorra Draoui Shereen Elserougi Chris Leach
https://lnkd.in/epzrmAXm
President, Cardiac Surgery at Medtronic
4moThank you very much Gianluca Torregrossa. Looking foward to seeing you at AATS in Toronto!